German Drug Price Freeze Confirmed For Four Years In Latest Reforms
This article was originally published in The Pink Sheet Daily
Executive Summary
Germany’s pharmaceutical sector reforms represent a mixed bag for industry, with the price freeze set to continue, while rebate levels to health insurers are slashed.